Keywords: اینترفرون تقویت شده; Lymphatic; Biologic; Therapeutic proteins; Pharmacokinetics; Biodistribution; Intravenous; Trastuzumab; Interferon; Pegylated interferon; IFN-PEG40; 60 kDa Pegylated interferon α2a, PEGASYS®; IFN-PEG12;  ~ 31 kDa Pegylated interferon α2b, PEG-Intro
مقالات ISI اینترفرون تقویت شده (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترفرون تقویت شده; ETV; Entecavir; LAMr; lamivudine resistance mutations; VBT; viral breakthrough; HBV; Hepatitis B virus; HCC; hepatocellular carcinoma; IFN-α-2b; interferon α-2b; PegIFN-α-2a; pegylated interferon; NAs; α-2a nucleos(t)ide analogues; LAM; lamivudine; AD
Keywords: اینترفرون تقویت شده; Anemia; Hepatitis C; Pegylated interferon; Reticulocyte production index
Keywords: اینترفرون تقویت شده; Pegylated interferon; Hepatitis C virus; Cardiovascular complications of interferon
Keywords: اینترفرون تقویت شده; Pegylated interferon; Children; Hepatitis C; Depression; Quality of life
A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-responders
Keywords: اینترفرون تقویت شده; Chronic hepatitis C; Cost-effectiveness analysis; Naïve; Pegylated interferon; Response-guided therapy;
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort
Keywords: اینترفرون تقویت شده; chronic hepatitis C; cost-effectiveness analysis; pegylated interferon; ribavirin; treatment-experienced;
Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapy
Keywords: اینترفرون تقویت شده; cccDNA; Chronic hepatitis B; HBcrAg; HBsAg; Hepatitis B core-related antigen; Hepatitis B virus; Pegylated interferon; Predictor; Stopping rule; Treatment response;
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
Keywords: اینترفرون تقویت شده; HCV; RASs; DAA; Virologic Treatment Failure; DAA; direct-acting antiviral; DCV; daclatasvir; EOT; end of treatment; GT; genotype; HCV; hepatitis C virus; LDV; ledipasvir; NS; nonstructural protein; PCR; polymerase chain reaction; PEG IFN; pegylated interf
The Mexican consensus on the treatment of hepatitis C
Keywords: اینترفرون تقویت شده; Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; AASLD; American Association for the Study of Liver Diseases; AFP; alpha-fetopro
Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients
Keywords: اینترفرون تقویت شده; Hepatitis B virus core protein; Chronic hepatitis B; Deep sequencing; HBeAg status; Treatment response; HBV; hepatitis B virus; CHB; chronic hepatitis B; NUC; nucleos(t)ide analogues; peg-IFN; pegylated interferon; HBsAg; hepatitis B surface antigen; HBc;
Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial
Keywords: اینترفرون تقویت شده; Myeloproliferative neoplasms; Essential thrombocytosis; Polycythemia vera; Myelofibrosis; Pegylated interferon;
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan
Keywords: اینترفرون تقویت شده; Chronic hepatitis C; Cost-effectiveness analysis; Naïve; Pegylated interferon; Ribavirin;
Impact of hepatitis B vaccination on HBsAg kinetics, interferon-inducible protein 10 level and recurrence of viremia
Keywords: اینترفرون تقویت شده; CccDNA; covalently closed circular DNA; CHB; chronic hepatitis B; ECLIA; Electrochemiluminescence immunoassay; ELISA; Enzyme-linked immunosorbent assay; HBsAg; HBV surface antigen; HCC; hepatocellular carcinoma; HOMA-IR; Homeostatic model assessment for i
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT)
Keywords: اینترفرون تقویت شده; HCV; hepatitis C virus; CHC; chronic hepatitis C; HCC; hepatocellular carcinoma; LT; liver transplantation; PEG-IFN; pegylated interferon; RBV; ribavirin; SVR; sustained virological response; ANRS; France REcherche Nord & sud Sida-HIV Hépatites-FRENSH; V
The role of quantitative hepatitis B surface antigen revisited
Keywords: اینترفرون تقویت شده; Hepatitis B; HBsAg; Pegylated interferon; Entecavir; Tenofovir; Antiviral treatment;
Hepatitis B and C
Keywords: اینترفرون تقویت شده; Hepatitis B; Hepatitis C; Sustained virologic response; Pegylated interferon; Direct-acting antiviral agents; Spontaneous viral clearance;
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement
Keywords: اینترفرون تقویت شده; HCV; hepatitis C virus; HCV-EHMs; HCV-extrahepatic manifestations; IFN; interferon; CV; cryoglobulinemic vasculitis; AVT; antiviral therapy; Peg-IFN; pegylated interferon; RBV; ribavirin; DAAs; direct-acting antiviral agents; FDA; food and drug administra
Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infection
Keywords: اینترفرون تقویت شده; Chronic hepatitis B; Antiviral therapy; IFN signaling pathway; STAT1; MX; Peg-IFN; pegylated interferon; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; NAs; nucleot(s)ide analogues; CHB; chronic hepatitis B; ETV; entecavir; ISGs; interf
Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferon
Keywords: اینترفرون تقویت شده; Hepatitis B treatment; PEG-IFN; HBV genotype; qHBsAg; HBeAg-negative; HBV; Hepatitis B virus; NA; nucleos(t)ide analogues; CHB; chronic hepatitis B; PEG-INF; pegylated interferon; HBsAg; hepatitis B surface antigen; ALT; alanine aminotransferase; HBeAg; h
Research ArticleBoceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients
Keywords: اینترفرون تقویت شده; MSM; men having sex with men; HCV; hepatitis C virus; AHCV; acute hepatitis C virus; PegIFN; pegylated interferon; SVR; sustained virological response; RBV; ribavirin; DAA; direct-acting antiviral; DAHHS; Dutch Acute HCV in HIV Study; cART; combination an
Effect of interleukin-10 gene promoter polymorphisms -1082 G/A and -592 C/A on response to therapy in children and adolescents with chronic hepatitis C virus infection
Keywords: اینترفرون تقویت شده; HCV; hepatitis C virus; Th1; Type 1 helper T cells; Th2; Type 2 helper T cells; IL; interleukin; SNPs; single nucleotide polymorphisms; PEG-IFN; pegylated interferon; AST; aspartate amino transferase; ALT; alanine amino transferase; GGT; gamma-glutamyl tr
Role of assessing liver fibrosis in management of chronic hepatitis C virus infection
Keywords: اینترفرون تقویت شده; Direct-acting antiviral; Hepatitis C; Liver biopsy; Non-invasive markers; Pegylated interferon;
Research ArticleSustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12Â weeks
Keywords: اینترفرون تقویت شده; HCV; hepatitis C virus; GT; genotype; SVR; sustained virologic response; SVR12; sustained virologic response 12Â weeks post-treatment; PegIFN; pegylated interferon; RBV; ribavirin; DAA; direct-acting antiviral; OBV; ombitasvir; PTV; paritaprevir; r; riton
Perspectives on dual hepatitis B and C infection in Taiwan
Keywords: اینترفرون تقویت شده; direct-acting antivirals; dual infection; hepatitis B virus; hepatitis C virus; pegylated interferon
Impact of HCV kinetics on treatment outcome differs by the type of real-time HCV assay in NS3/4A protease inhibitor-based triple therapy
Keywords: اینترفرون تقویت شده; Hepatitis C virus; Protease inhibitor; Real-time PCR; Pegylated interferon; Simeprevir;
Adherence to ribavirin in chronic hepatitis C patients on antiviral treatment: Results from a randomized controlled trial using real-time medication monitoring
Keywords: اینترفرون تقویت شده; CHC; chronic hepatitis C; SMS; Short Message Service; RTMM; real-time medication monitoring; HCV; hepatitis C virus; SVR; sustained virologic response; PEG-interferon; pegylated interferon; AE; adverse event; EVR; early virologic response; WBC; white bloo
Research ArticlePrioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
Keywords: اینترفرون تقویت شده; HCV; hepatitis C virus; PWID; people who inject drugs; PegIFN; pegylated interferon; RBV; ribavirin; IFN-free; interferon-free; DAA; direct-acting antiviral; HCC; hepatocellular carcinoma; QALY; quality adjusted life-year; NMB; net monetary benefit; ESLD;
Research ArticleEfficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials
Keywords: اینترفرون تقویت شده; HCV; hepatitis C virus; GT; genotype; TPV; telaprevir; PegIFN; pegylated interferon; RBV; ribavirin; SVR; sustained virologic response; DAA; direct-acting antiviral agents; OBV; ombitasvir; PTV; paritaprevir; r; ritonavir; DSV; dasabuvir; IL28B; interleuk
ReviewIdeal oral combinations to eradicate HCV: The role of ribavirin
Keywords: اینترفرون تقویت شده; HCV; hepatitis C virus; SVR; sustained virological response; RBV; ribavirin; IFN; interferon; Peg-IFN; pegylated interferon; DAA; direct-acting antiviral; ALT; alanine transaminase; GTP; guanosine triphosphate; IMPDH; inosine monophosphate dehydrogenase;
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension
Keywords: اینترفرون تقویت شده; Esophagus; Bleeding; Long-Term Outcome; Portal Pressure; ALT; alanine-aminotransferase; DAA; direct-acting antivirals; EGS; esophageal gastroscopy; EV; esophageal varices; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; LD; liver decompensation; LT
Diagnostics in hepatitis C: The end of response-guided therapy?
Keywords: اینترفرون تقویت شده; Response-guided therapy; Pegylated interferon; Direct-acting; Antivirals; On-treatment HCV RNA; HCV RNA assay
A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Keywords: اینترفرون تقویت شده; HALT-C cohort; Viral hepatitis; Cirrhosis; Hepatitis C; Liver cancer; adiponutrin; CI; confidence interval; HALT-C; Hepatitis C Antiviral Long-Term Treatment against Cirrhosis; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; NASH; nonalcoholic stea
Chronic Hepatitis C Infection in Children
Keywords: اینترفرون تقویت شده; Hepatitis C virus; Chronic hepatitis C; Children; Treatment; Pegylated interferon; Ribavirin; Direct-acting antivirals;
Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis
Keywords: اینترفرون تقویت شده; Hepatitis C; Pegylated interferon; Dialysis; Renal insufficiency
Optimal Duration of Pegylated Interferon Plus Ribavirin Therapy for Chronic Hepatitis C Genotype 3 Patients who do not Achieve Rapid Virological Response
Keywords: اینترفرون تقویت شده; 36 weeks therapy; chronic hepatitis C; pegylated interferon; ribavirin; RVR non-achieversHCV, Hepatitis C virus; CHC, Chronic hepatitis C; SVR, sustained virologic response; EVR, early virological response; HIV, Human Immunodeficiency virus; HBV, hepatiti
Roles of ITPA and IL28B genotypes in chronic Hepatitis C patients treated with peginterferon plus ribavirin in Tunisian population
Keywords: اینترفرون تقویت شده; ITPA; inosine triphosphate; SVR; sustained virological response; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; PEG-IFN; pegylated interferon; GWAS; Genome Wide Association Study; SNPs; single nucleotide polymorphisms; III IFN; interferon III; IL2
Research ArticleWhat is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?
Keywords: اینترفرون تقویت شده; HCV; hepatitis C virus; PWID; people who inject drugs; SVR; sustained viral response; ESLD; end-stage liver disease; PegIFN & R; pegylated interferon and ribavirin; Hepatitis C virus; Antiviral therapy; Pegylated interferon; Sustained viral response;
Research ArticleTelbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy
Keywords: اینترفرون تقویت شده; PegIFN; pegylated interferon; CHB; chronic hepatitis B; HBV; hepatitis B virus; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV DNA; hepatitis B virus DNA; LdT; telbivudine; ULN; upper limit of normal; LSMean; least square means; PCR
Research ArticleSofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry
Keywords: اینترفرون تقویت شده; HCV; hepatitis C virus; PegIFNα; pegylated interferon; RBV; ribavirin; SVR; sustained virologic response; DAAs; direct-acting antiviral agents; APRI; aminotransferase:platelet ratio index; ULN; upper limit of normal; LLOQ; lower limit of quantitation; NI
Período de lead-in y semana 8 como herramientas de predicción de la respuesta en el tratamiento con boceprevir: estudio retrospectivo de la práctica clínica real en España
Keywords: اینترفرون تقویت شده; VHC; Lead-in; Boceprevir; Peginterferón; Ribavirina; Respuesta virológica sostenidaHCV; lead-in; boceprevir; pegylated interferon; ribavirin; SVR
Research ArticleQuantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study
Keywords: اینترفرون تقویت شده; CHB; chronic hepatitis B; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; cccDNA; covalently closed circular DNA; HBsAg; hepatitis B surface antigen; peg-IFN; pegylated interferon; HBeAg; hepatitis B e antigen; ETV; entecavir; TDF; tenofovir disopr
Hepatitis C
Keywords: اینترفرون تقویت شده; Hepatitis C; Children; Perinatal transmission; Pegylated interferon; Ribavirin; Direct acting antiviral;
In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance
Keywords: اینترفرون تقویت شده; DAA; direct acting antivirals; SOC; standard of care; Peg_IFN; pegylated interferon; RBV; ribavirin; RVR; rapid virological response; cEVR; complete early virological response; vRVR; very rapid viral response; 2â²-C-MeCyt; 2â²-C-methylcytidine; TCA; thi
Boceprevir for Chronic Genotype 1 Hepatitis C Virus in the Current Health Care Setting in Greece: A Cost-effectiveness Analysis
Keywords: اینترفرون تقویت شده; boceprevir; chronic hepatitis C; cost-effectiveness; genotype 1; pegylated interferon; ribavirin;
Sarcoïdose chez un patient traité par interféron pégylé pour une hépatite chronique C
Keywords: اینترفرون تقویت شده; Hépatite C; Interféron pégylé; Sarcoïdose; Hepatitis C; Pegylated interferon; Sarcoidosis;
Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: case report and literature review
Keywords: اینترفرون تقویت شده; Pegylated interferon; Adverse drug reaction; Cardiotoxicity; Thyroid dysfunction
Clinical Profile and Response to Treatment with Pegylated Interferon α 2b and Ribavirin in Chronic Hepatitis C—A Reappraisal from a Tertiary Care Center in Northern India
Keywords: اینترفرون تقویت شده; chronic hepatitis; genotype; hepatitis C virus; pegylated interferon; therapeutic responseCBC, complete blood count; CBC, complete blood count; CH–C, chronic hepatitis C; DAA, direct acting antivirals; ETR, end of therapy; LFT, liver function test; Peg-IF
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
Keywords: اینترفرون تقویت شده; MERS-CoV; Interferon; Ribavirin; Pegylated interferon
Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment
Keywords: اینترفرون تقویت شده; Complement C3; Complement C4; Chronic hepatitis C; Pegylated interferon; Ribavirin